Administration Core
Administration Core
批准号:
10268759
负责人:
SCOTT H KAUFMANN
金额:
$13.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
未结题
起止时间:
2009-07-01 至 2026-08-30
关键词:
Advisory CommitteesAdvocateClinicClinical ManagementClinical TrialsCollaborationsCollectionCommunicationCommunitiesDetectionDevelopmentDiseaseFundingGoalsInfrastructureLeadershipMalignant NeoplasmsMalignant neoplasm of ovaryMayo Clinic Cancer CenterMethodsMinorityMonitorOccupational activity of managing financesOvarianPatient advocacyPerformancePopulation ResearchPreventionProceduresProgress ReportsReportingResearchResearch PersonnelResearch Project GrantsResearch SupportStructureTranslational ResearchTranslationsWomanWorkcareerdesigninnovationmeetingsmemberprogramsrecruitresearch and developmentresearch study
中文摘要
摘要-行政核心
马约诊所卵巢癌SPORE的总体目标是促进卵巢癌的创新研究。
并加快将发现转化为新的和更好的预防,检测和治疗方法。
治疗这种疾病。行政核心通过充当
马约卵巢孢子在6-10年的资金组织中心。过去5年的主要变化
多年来,包括i)为核心开发了一位新的联合领导人杰米·巴克韦尔-加梅兹,
ii)招聘了几名新的外部咨询委员会(EAB)成员,反映了SPORE的新方向
项目在下一个资助期(11-15年),行政核心将继续提供
为SPORE领导层、研究项目、科学核心和
发展研究计划(DRP)和职业提升计划(CEP)。
具体而言,行政核心将:1)为SPORE提供领导和组织支持
调查员; 2)监督SPORE研究项目科学审查的正式程序; 3)监督和
促进所有核心的努力; 4)管理和协调SPORE财务活动; 5)监控应计项目,包括
所有马约卵巢孢子临床试验、人群研究和生物标本的少数累积
收集; 6)为DRP和CEP领导提供指导和行政支持; 7)促进
执行委员会的活动并执行其决定; 8)促进SPORE的参与
9)促进EAB和内部科学咨询委员会(ISAC)对SPORE的审查;
10)组织每月的孢子科学会议,研讨会和年度务虚会; 11)确保持续的
将卵巢孢子与马约诊所癌症中心及其妇女癌症计划相结合;
12)作为马约卵巢孢子,NCI孢子计划,其他
马约孢子,和外部合作者; 13)确定和催化卵巢癌的研究合作,
包括与其他卵巢孢子的合作; 14)沟通孢子相关的研究
向马约调查人员提供发展和机会;以及15)协助SPORE主任准备报告
卵巢孢子活动,包括年度进展报告和竞争性更新申请。
英文摘要
ABSTRACT – ADMINISTRATIVE CORE
The overall goals of the Mayo Clinic SPORE in Ovarian Cancer are to stimulate innovative research in ovarian
cancer and to expedite the translation of discoveries into new and better methods of prevention, detection and
treatment of this disease. The Administrative Core has facilitated progress toward these goals by serving as the
organizational hub of the Mayo Ovarian SPORE during Years 6-10 of funding. Major changes during the past 5
years have included the i) development of a new co-leader, Jamie Bakkum-Gamez, for the Core, and
ii) recruitment of several new External Advisory Board (EAB) Members, reflecting new directions in the SPORE
projects. During the next funding period (Years 11-15), the Administrative Core will continue to provide
organizational and communications support for the SPORE leadership, research projects, scientific cores and
developmental programs [Developmental Research Program (DRP) and Career Enhancement Program (CEP)].
Specifically, the Administrative Core will: 1) Provide leadership and organizational support to SPORE
investigators; 2) oversee formal procedures for scientific review of SPORE research projects; 3) oversee and
facilitate the efforts of all cores; 4) manage and coordinate SPORE fiscal activities; 5) monitor accrual, including
minority accrual, to all Mayo Ovarian SPORE clinical trials, population research studies and biospecimen
collections; 6) provide guidance and administrative support to the DRP and CEP leadership; 7) facilitate the
activities of the Executive Committee and implement its decisions; 8) facilitate engagement of the SPORE
advocates; 9) facilitate reviews of the SPORE by the EAB and Internal Scientific Advisory Committee (ISAC);
10) organize monthly SPORE scientific meetings, seminars, and the annual retreat; 11) assure ongoing
integration of the Ovarian SPORE with the Mayo Clinic Cancer Center and its Women’s Cancer Program;
12) serve as the administrative liaison between the Mayo Ovarian SPORE, the NCI SPORE Program, other
Mayo SPOREs, and external collaborators; 13) identify and catalyze research collaborations in ovarian cancer,
including collaborations with the other Ovarian SPOREs; 14) communicate SPORE-related research
developments and opportunities to Mayo investigators; and 15) assist the SPORE Director in preparing reports
of Ovarian SPORE activities, including annual progress reports and the competitive renewal application.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MSTP at Mayo Clinic Rochester
-
批准号:10409857
-
项目类别:
-
资助金额:$116.11万
-
财政年份:2023
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
-
批准号:10438886
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2021
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
-
批准号:10296087
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2021
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
-
批准号:10656207
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2021
-
负责人:SCOTT H KAUFMANN
-
依托单位:
BAK Autoactivation in Hematological Malignancies
-
批准号:10425322
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2020
-
负责人:SCOTT H KAUFMANN
-
依托单位:
BAK Autoactivation in Hematological Malignancies
-
批准号:10684892
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2020
-
负责人:SCOTT H KAUFMANN
-
依托单位:
BAK Autoactivation in Hematological Malignancies
-
批准号:10188459
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2020
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Deubiquitinases in regulation of BRCA1 pathway
-
批准号:10006119
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2016
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Regulation of Death Ligand-Induced Killing
-
批准号:8884794
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2015
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
-
批准号:9020939
-
项目类别:
-
资助金额:$40.39万
-
财政年份:2015
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Anticancer drug-induced BH3-only protein.Bak interactions
-
批准号:8273913
-
项目类别:
-
资助金额:$33.26万
-
财政年份:2012
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Anticancer drug-induced BH3-only protein.Bak interactions
-
批准号:8640764
-
项目类别:
-
资助金额:$31.18万
-
财政年份:2012
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Anticancer drug-induced BH3-only protein.Bak interactions
-
批准号:8828123
-
项目类别:
-
资助金额:$32.15万
-
财政年份:2012
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Anticancer drug-induced BH3-only protein.Bak interactions
-
批准号:8459985
-
项目类别:
-
资助金额:$30.28万
-
财政年份:2012
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Anticancer drug-induced BH3-only protein.Bak interactions
-
批准号:9056441
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2012
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Project 2: Next Generation TOP1 Inhibition for the Treatment of Ovarian Cancer
-
批准号:10452720
-
项目类别:
-
资助金额:$26.16万
-
财政年份:2009
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Project 1 - PARP Project
-
批准号:8932128
-
项目类别:
-
资助金额:$17.31万
-
财政年份:2009
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Administration Core
-
批准号:10705035
-
项目类别:
-
资助金额:$12.96万
-
财政年份:2009
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Mayo Clinic Ovarian Cancer SPORE
-
批准号:10452715
-
项目类别:
-
资助金额:$174.98万
-
财政年份:2009
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Project 1 - PARP Project
-
批准号:9333234
-
项目类别:
-
资助金额:$18.87万
-
财政年份:2009
-
负责人:SCOTT H KAUFMANN
-
依托单位:
海外基金